OneMedNet (ONMD) Net Income towards Common Stockholders (2021 - 2026)

OneMedNet (ONMD) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$2.6 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 13.61% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$3.6 million, a 65.69% increase from a year earlier, with the FY2025 full-year figure at $623000.0, up 850.6% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$2.6 million, up from -$3.1 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for ONMD reached as high as $2.8 million in Q2 2025 and fell as low as -$3.6 million in Q2 2024.
• Historically, Net Income towards Common Stockholders has averaged -$960294.2 across 5 years, with a median of -$816520.0 in 2023.
• Across the five-year window, Net Income towards Common Stockholders soared 130011.72% in 2022 and sank 69481.23% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$3.0 million in 2022, then soared by 131.96% to $954660.0 in 2023, then tumbled by 382.4% to -$2.7 million in 2024, then decreased by 14.61% to -$3.1 million in 2025, then advanced by 17.09% to -$2.6 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$2.6 million in Q1 2026, -$3.1 million in Q4 2025, and -$741000.0 in Q3 2025.